Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.
<iframe src="https://statesidedaily.com/embed/cluster/60d93b552141d5182b102d2572f8eb32f642fee7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value"></iframe>